Watch breaking news videos and read news updates about Merck on FOXBusiness.com.
LATEST VIDEOS
Economy Headed for a Jobless Recovery
11/19/2009|FOX Business Morning
Cantor Fitzgerald Chief Global Strategist Stephen Pope on why the economy is facing a jobless recovery, not a double-dip recession.
Earl 'The Pearl' Monroe on Diabetes
11/09/2009|Opening Bell
NBA Hall of Famer Earl 'The Pearl' Monroe on fighting diabetes.
Election's Effect on Wall Street
11/04/2009|Bulls and Bears
Merk Investments's Axel Merk on how Wall Street is responding to the election results.
Huntsman on Dangers of Oil Speculation
10/28/2009|Cavuto
Huntsman Corp. Executive Chairman Jon Huntsman Sr. on the global energy outlook.
Mossberg on Apple's Updated Macs
10/22/2009|FOX Business
Wall Street Journal Personal Technology Columnist Walt Mossberg on Apple's updated computer lines.
Merk Mutual Funds President Axel Merk on why the current rally has the economy headed toward inflation.
Onyx CEO on the Proteolix Deal
10/12/2009|Opening Bell
Onyx Pharmaceuticals CEO Tony Coles on the pharmaceutical company's purchase of Proteolix for $276 million.
LATEST STORIES
Merck Receives Recommendation for Fertility Drug
| FOXBusiness| Markets
FOXBusiness A European advisory committee has recommended approval for Merck & Co.'s (MRK) new fertility drug Elonva. The Committee for ..... approved the treatment would be sold in the European Union. Shares of Merck rose 3% in Friday trading.
Story|11/20/2009
Merck KGaA Cut To Hold From Buy At Citi
| MarketWatch Pulse| Markets
By Barbara Kollmeyer MarketWatch Pulse MADRID -- German pharmaceutical and chemical company Merck KGaA was downgraded to hold from buy on Friday at Citigroup, which said the risk-reward looks evenly balanced. The rejection
Story|11/20/2009
Abbott Laboratories Reports Positive Results on Niaspan
FOXBusiness| Markets
Laboratories (ABT) announced on Monday positive results of cholesterol drug Niaspan.
Story|11/16/2009
Merck, Abbott Rise After Study
FOXBusiness| Markets
FOXBusiness Shares of pharmaceutical company Merck (MRK) rose 2% Monday following a study ..... remains challenging, but its importance to Merck diminishes over time." In the drug ..... while Zetia patients had no change. Merck added 2% on Monday to $33.81, and
Story|11/16/2009
Merck, Bristol-Myers Lead Drug Stocks Higher
| MarketWatch Pulse| Markets
By Val Brickates Kennedy MarketWatch Pulse BOSTON -- Merck & Co. and Bristol-Myers Squibb led drugs stocks higher early ..... Biotechnology Index edged up 0.4% to 895.04. Shares of Merck were up 3% at $34.24, while Bristol-Myers shares gained
Story|11/16/2009
Bausch & Lomb Names Former Schering CEO to Board
FOXBusiness| Markets
maker of personal products announced on Thursday. Hassan served as Schering's CEO from 2003 until the company was acquired by Merck (MRK) in October. Hassan previously worked for Pharmacia, which was sold to Pfizer (PFE) in 2003. On Thursday, Bausch
Story|11/12/2009
Market Winners & Losers: MBIA, Molson Coors
| FOXBusiness| Markets
shares closed at $57.93, a gain of $3.53 on the day. Merck & Co. (MRK) The pharmaceutical giant gained 6.4% as its ..... closed and the company reiterated its positive financial target. Merck shares ended the session at $32.64, up $1.97 on the day
Story|11/04/2009
Merck Cuts Won't Come in Next Couple Days
| FOXBusiness| Markets
Darryl R. Isherwood FOXBusiness Job cuts are still coming but not this week, Merck & Co.(MRK) Chief Executive Richard Clark said Wednesday, according to Dow Jones. The company, which yesterday acquired Schering
Story|11/04/2009
Merck Leads Drug Stocks Higher
| MarketWatch Pulse| Markets
Val Brickates Kennedy MarketWatch Pulse BOSTON -- Merck led drug stocks higher early Wednesday as the pharmaceutical ..... Biotechnology Index climbed 0.8% to 880.91. Shares of Merck were up almost 3% at $41.46. Shares of Schering-Plough
Story|11/04/2009
Merck, Schering-Plough To Complete Merger Tuesday
| MarketWatch Pulse| Markets
Brickates Kennedy MarketWatch Pulse BOSTON -- Merck & Co. and Schering-Plough Corp. said ..... The combined company will be known as Merck , with shares trading under the symbol ..... for each Schering-Plough share. Each Merck share will automatically convert to one
Story|11/03/2009